Table 2.
Variable | AA (n = 15) | PLA (n = 16) | Significance |
Wingate Mean Power (W·kg-1) | |||
Day 0 | 8.3 ± 1.2 | 8.9 ± 0.7 | Group: 0.17 |
Day 25 | 8.5 ± 1.1 | 8.9 ± 0.8 | Time: 0.35 |
Day 50 | 8.6 ± 1.2 | 9.1 ± 0.7 | G × T: 0.08 |
Wingate Peak Power (W·kg-1) | |||
Day 0 | 16.9 ± 3.1 | 18.3 ± 2.6 | Group: 0.50 |
Day 25 | 17.9 ± 2.6b | 18.3 ± 2.8 | Time: 0.11 |
Day 50 | 18.1 ± 2.6b | 18.1 ± 2.8 | G × T: 0.02 |
Wingate Total Work (Joules)a | |||
Day 0 | 21,102 ± 3,620 | 22,388 ± 4,222 | Group: 0.18 |
Day 25 | 21,658 ± 3,307 | 23,340 ± 3,909 | Time: 0.001 |
Day 50 | 22,394 ± 4,096 | 23,899 ± 3,493 | G × T: 0.052 |
Values are expressed as means ± SD.
AA: Arachidonic acid, PLA: placebo.
aSignificant main effect over time, p < 0.01.
bSignificant within-group difference from baseline values, p < 0.05.